The therapeutic effect of the combination of altplas and ibtifibatide (integrilin) in comparison with altplas (r-TPA) alone, in the treatment of acute ischemic stroke
Phase 2
- Conditions
- Acute Ischemic Stroke.Cerebellar stroke syndromeG46.4
- Registration Number
- IRCT20170117032025N9
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients should have a serious measurable neurological defect on the NIHSS stroke scale due to focal ischemia of the brain (NIHSS score> 5).
Intravenous therapy should be started within 3 hours of the onset of stroke symptoms.
Exclusion Criteria
Suspect subarachnoid hemorrhage, even if the brain CT scan is normal
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cerebral hemorrhage. Timepoint: Admission, discharge and three months later. Method of measurement: By NIHSS(National Institutes of Health Stroke Scale) criteria.
- Secondary Outcome Measures
Name Time Method